Overview

Definition:
-Superficial parotidectomy is a surgical procedure to remove the superficial lobe of the parotid gland
-It is commonly performed for benign and malignant tumors arising in this region
-Intraoperative facial nerve monitoring is crucial to preserve facial nerve function.
Epidemiology:
-Parotid gland tumors are the most common salivary gland neoplasms, accounting for approximately 80% of cases
-Benign tumors are more frequent (70-80%), with pleomorphic adenoma being the most common
-Malignant tumors are less common but require aggressive management.
Clinical Significance:
-Accurate surgical resection with preservation of the facial nerve is paramount for both oncologic control and cosmetic/functional outcomes
-Understanding the anatomy and potential complications is vital for surgical trainees preparing for DNB and NEET SS examinations.

Indications

Benign Neoplasms:
-Pleomorphic adenoma
-Warthin's tumor
-Myoepithelioma
-Benign lymphoepithelial lesions.
Malignant Neoplasms:
-Low-grade mucoepidermoid carcinoma
-Adenoid cystic carcinoma
-Squamous cell carcinoma
-Metastatic disease.
Inflammatory Conditions:
-Recurrent parotitis unresponsive to medical management
-Chronic sialadenitis with mass formation.
Diagnostic Biopsy: When fine needle aspiration cytology is inconclusive or suspicious for malignancy.

Preoperative Preparation

History And Physical:
-Detailed history of mass growth, pain, facial weakness, or neurological deficits
-Palpation for mass characteristics, mobility, and involvement of surrounding structures
-Examination of cranial nerves, especially facial nerve function.
Imaging:
-Ultrasound of the parotid gland for initial assessment
-CT scan or MRI with contrast is essential for tumor size, extent, relationship to the facial nerve, and involvement of adjacent structures
-MRI is superior for soft tissue characterization.
Biopsy:
-Fine needle aspiration cytology (FNAC) for suspected tumors to determine benign vs
-malignant nature
-Core needle biopsy may be used for specific indications.
Anesthesia Considerations:
-General anesthesia with endotracheal intubation is typically required
-Careful anesthetic management is needed due to the proximity of the airway and the need for prone positioning in some cases.

Surgical Procedure

Anesthesia And Positioning:
-General anesthesia is administered
-The patient is placed in a supine position with the head turned away from the side of surgery
-A surgical head rest may be used.
Incision:
-Preauricular incision, extending inferiorly and posteriorly along the sternocleidomastoid muscle
-S-shaped incision is common to provide adequate exposure and facilitate closure.
Dissection And Nerve Identification:
-Elevate skin flaps anteriorly and inferiorly
-Identify the tragal pointer and the anterior border of the sternocleidomastoid muscle to locate the greater auricular nerve
-Dissect along the superficial musculoaponeurotic system (SMAS) to identify the main trunk or branches of the facial nerve
-Use nerve stimulator for identification and monitoring.
Gland And Tumor Excision:
-Careful dissection around the identified facial nerve branches
-Identify and ligate the external carotid artery and its branches supplying the gland
-Excise the superficial lobe of the parotid gland with the tumor, ensuring adequate margins
-If malignancy is suspected, wider margins are required.
Facial Nerve Monitoring:
-Utilize intraoperative neuromonitoring (IONM) with a nerve stimulator and electromyography (EMG) to confirm facial nerve integrity during dissection
-Stimulation of suspected nerve branches helps differentiate them from surrounding tissues and assess their functionality.
Hemostasis And Drainage:
-Meticulous hemostasis is achieved using electrocautery and ligation of vessels
-A surgical drain (e.g., Jackson-Pratt) is usually placed to prevent hematoma and seroma formation.
Closure:
-Repair of SMAS layer if incised
-Layered closure of subcutaneous tissue and skin
-Drains are typically removed when output is minimal.

Postoperative Care

Pain Management:
-Analgesics (opioids, NSAIDs) as needed
-Monitor for signs of infection or complications.
Wound Care:
-Keep incision clean and dry
-Dressing changes as per protocol
-Monitor for signs of wound dehiscence or infection.
Drain Management:
-Monitor drain output
-Remove when output is less than 20-30 ml/24 hours
-Assess for potential complications like salivary leak.
Diet:
-Soft diet initially, progressing as tolerated
-Avoid very hot or spicy foods that may stimulate salivary flow and cause discomfort.
Facial Nerve Function Assessment:
-Regular assessment of facial nerve function
-Educate patient on potential temporary or permanent deficits and management strategies.

Complications

Early Complications:
-Facial nerve injury (temporary or permanent weakness/paralysis)
-Hematoma or seroma formation
-Surgical site infection
-Salivary fistula or leak
-Bleeding.
Late Complications:
-Frey's syndrome (gustatory sweating)
-Facial asymmetry or contour deformity
-Tumor recurrence (especially for malignant tumors)
-Chronic pain.
Prevention Strategies:
-Meticulous surgical technique with clear identification and monitoring of the facial nerve
-Careful flap elevation
-Adequate hemostasis
-Use of drains
-Prophylactic antibiotics
-Patient education regarding postoperative care and potential sequelae.

Key Points

Exam Focus:
-The key to superficial parotidectomy is identifying and preserving the facial nerve
-Understanding the landmarks for nerve identification (e.g., tragal pointer, mastoid tip, digastric muscle) and the role of intraoperative neuromonitoring are high-yield for DNB/NEET SS.
Clinical Pearls:
-Always dissect superficial to the facial nerve when approaching tumors in the superficial lobe
-Remember that the facial nerve branches at the pes anserinus, deep to the retromandibular vein
-In case of suspicion of malignancy, frozen section analysis of margins during surgery can be invaluable.
Common Mistakes:
-Inadequate exposure leading to blind dissection near the nerve
-Failure to identify the main trunk or key branches of the facial nerve
-Inadequate margin clearance in malignant tumors
-Not addressing Frey's syndrome preoperatively or postoperatively.